Company Search:
Advanced Search
Sponsored Links
Obi Pharma Inc Company Snapshot
Obi Pharma Inc operates in the Commercial physical research sector. In addition to historical fundamental analyses, the complete report available to purchase compares Obi Pharma Inc with three other companies in this sector in Taiwan: Taigen Biopharmaceuticals Holdings Ltd (2016 sales of 146.02 million Taiwanese Dollars [US$4.93 million] of which 90% was Medical Development), Taiwan Liposome Co Limited (41.67 million Taiwanese Dollars [US$1.41 million] of which 100% was Biopharmaceutical), and Tpg Biologics Inc (48.22 million Taiwanese Dollars [US$1.63 million] ).

Sales Analysis.
Company ReportsSubscriptions
Looking For More?
Purchace an In-Depth Report
Obi Pharma Inc
  Stock Performance Chart for Obi Pharma Inc
  Stock Data: Recent Stock Performance:
  Current Price (1/12/2018): 169.00
(Figures in Taiwanese Dollars)
1 Week 14.2%   13 Weeks 18.6%  
4 Weeks 4.6%   52 Weeks -37.6%  
Obi Pharma Inc Key Data:
  Ticker: 4174 Country: Taiwan
  Exchanges: TAI Major Industry: Commercial Services & Supplies
    Sub Industry: Commercial Physical Research
  2016 Sales 92,422,000
(Year Ending Jan 2017).
Employees: 40
  Currency: Taiwanese Dollars Market Cap: 28,941,870,906
  Fiscal Yr Ends: December Shares Outstanding: 171,253,674
  Share Type: Ordinary Closely Held Shares: 70,368,000
Sponsored Links
Feedback | Terms and Conditions | Privacy Policy | Site Index
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.